Sanara MedTech (SMTI) EBITDA Margin (2010 - 2026)
Sanara MedTech's (SMTI) quarterly EBITDA Margin came in at 15.33% in Q1 2026, up 383.0% YoY from 3.17% in Q1 2025, and down 9.96% on a QoQ basis from 17.03% in Q4 2025.
Sanara MedTech (SMTI) EBITDA Margin (2010 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 16 years of EBITDA Margin data on file, last reported at 15.33% in Q1 2026.
- Quarterly EBITDA Margin rose 383.0% year-over-year to 15.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.37% (up 456.0% YoY) and the FY2025 annual result came in at 16.5%, up 594.0% from the prior year.
- EBITDA Margin eased to 15.33% in Q1 2026, from 17.03% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 18.64% in Q3 2025 to a low of 35.55% in Q1 2022.
- A 5-year average of 0.97% and a median of 2.54% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin sank 1865 bps — and 2023, when it soared 3313 bps.
- Tracing SMTI's EBITDA Margin over 5 years: stood at 20.39% in 2022, then surged by 112 bps to 2.54% in 2023, then surged by 507 bps to 15.41% in 2024, then advanced by 11 bps to 17.03% in 2025, then decreased by 10 bps to 15.33% in 2026.
- The last three EBITDA Margin figures came in at 15.33% (Q1 2026), 17.03% (Q4 2025), and 18.64% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 7.33% |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.33% |
| Dec 31, 2025 | 17.03% |
| Sep 30, 2025 | 18.64% |
| Jun 30, 2025 | 10.32% |
| Mar 31, 2025 | 11.50% |
| Dec 31, 2024 | 15.41% |
| Sep 30, 2024 | 11.83% |
| Jun 30, 2024 | 2.94% |
| Mar 31, 2024 | 1.68% |
| Dec 31, 2023 | 2.54% |
| Sep 30, 2023 | 1.66% |
| Jun 30, 2023 | -1.88% |
| Mar 31, 2023 | -7.84% |
| Dec 31, 2022 | -20.39% |
| Sep 30, 2022 | -24.78% |
| Jun 30, 2022 | -35.00% |
| Mar 31, 2022 | -35.55% |
| Dec 31, 2021 | -48.52% |
| Sep 30, 2021 | -31.83% |
| Jun 30, 2021 | -16.35% |